1. Home
  2. VNDA vs AFRI Comparison

VNDA vs AFRI Comparison

Compare VNDA & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • AFRI
  • Stock Information
  • Founded
  • VNDA N/A
  • AFRI 1943
  • Country
  • VNDA United States
  • AFRI Gibraltar
  • Employees
  • VNDA N/A
  • AFRI N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • AFRI Packaged Foods
  • Sector
  • VNDA Health Care
  • AFRI Consumer Staples
  • Exchange
  • VNDA Nasdaq
  • AFRI Nasdaq
  • Market Cap
  • VNDA 362.6M
  • AFRI 283.6M
  • IPO Year
  • VNDA 2006
  • AFRI N/A
  • Fundamental
  • Price
  • VNDA $6.11
  • AFRI $11.10
  • Analyst Decision
  • VNDA Buy
  • AFRI
  • Analyst Count
  • VNDA 1
  • AFRI 0
  • Target Price
  • VNDA $11.00
  • AFRI N/A
  • AVG Volume (30 Days)
  • VNDA 885.4K
  • AFRI 19.4K
  • Earning Date
  • VNDA 07-29-2024
  • AFRI 04-30-2024
  • Dividend Yield
  • VNDA N/A
  • AFRI N/A
  • EPS Growth
  • VNDA N/A
  • AFRI N/A
  • EPS
  • VNDA N/A
  • AFRI N/A
  • Revenue
  • VNDA $177,604,000.00
  • AFRI $305,476,000.00
  • Revenue This Year
  • VNDA $2.98
  • AFRI N/A
  • Revenue Next Year
  • VNDA $19.49
  • AFRI N/A
  • P/E Ratio
  • VNDA N/A
  • AFRI N/A
  • Revenue Growth
  • VNDA N/A
  • AFRI 16.74
  • 52 Week Low
  • VNDA $3.30
  • AFRI $9.63
  • 52 Week High
  • VNDA $6.75
  • AFRI $12.00
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 58.51
  • AFRI 54.94
  • Support Level
  • VNDA $5.89
  • AFRI $10.61
  • Resistance Level
  • VNDA $6.33
  • AFRI $11.26
  • Average True Range (ATR)
  • VNDA 0.25
  • AFRI 0.38
  • MACD
  • VNDA 0.05
  • AFRI 0.03
  • Stochastic Oscillator
  • VNDA 81.67
  • AFRI 84.91

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About AFRI Forafric Global PLC

Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.

Share on Social Networks: